Microbot Medical
MBOT
25 hedge funds and large institutions have $933K invested in Microbot Medical in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 12 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 5
0.47% less ownership
Funds ownership: 6.8% → 6.33% (-0.47%)
16% less capital invested
Capital invested by funds: $1.11M → $933K (-$174K)
29% less funds holding
Funds holding: 35 → 25 (-10)
83% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$43.4K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$12K |
| 3 |
HH
Hilltop Holdings
Dallas,
Texas
|
+$5.12K |
| 4 |
ITIM
Indiana Trust & Investment Management
Mishawaka,
Indiana
|
+$877 |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$16 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$29.9K |
| 2 |
TFS
Thoroughbred Financial Services
Brentwood,
Tennessee
|
-$26.6K |
| 3 |
VPIM
Vanguard Personalized Indexing Management
Oakland,
California
|
-$15.8K |
| 4 |
VF
Virtu Financial
New York
|
-$14K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$10.6K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
VPIM
26
Vanguard Personalized Indexing Management
Oakland,
California
| – | -$15.8K | -15,494 | Closed |
|
|
VF
27
Virtu Financial
New York
| – | -$14K | -13,379 | Closed |
|
|
28
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$10.6K | -10,404 | Closed |
|
29
Group One Trading
Chicago,
Illinois
| – | -$4.65K | -4,560 | Closed |
|
30
Qube Research & Technologies (QRT)
London,
United Kingdom
| – | -$714 | -700 | Closed |
|
31
JP Morgan Chase
New York
| – | -$190 | -186 | Closed |
|
|
HT
32
Headlands Technologies
Chicago,
Illinois
| – | -$172 | -169 | Closed |
|
33
Fidelity Investments
Boston,
Massachusetts
| – | -$7 | -7 | Closed |
|
|
FRA
34
Front Row Advisors
Tiburon,
California
| – | -$1 | -1 | Closed |
|
|
NFSG
35
Newbridge Financial Services Group
Boca Raton,
Florida
| – | -$1 | -1 | Closed |
|
36
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| – | -$1 | -1 | Closed |
|
|
HWM
37
Hemington Wealth Management
Falls Church,
Virginia
| – | +$1 | +1 | New |
|
MBOT Hedge Fund Activity: Q3 2024 in Review
25 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q3 2024, worth a combined $933K — down 16% from $1.11M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of MBOT and 2 opened new positions — a net loss of 10 holders — while 5 trimmed existing stakes and 5 added.
The largest buyer was UBS Group, adding an estimated $43.4K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $29.9K sold.
- 25 institutional investors held Microbot Medical (MBOT) as of Q3 2024, down from 35 in Q2 2024.
- Funds reported $933K of Microbot Medical stock for Q3 2024, down 16% quarter-over-quarter.
- 2 funds opened new Microbot Medical positions in Q3 2024 and 12 closed out, a net change of -10 holders.
- The largest Microbot Medical buyer in Q3 2024 was UBS Group, an estimated $43.4K added.
- The largest Microbot Medical seller in Q3 2024 was Renaissance Technologies, an estimated $29.9K sold.
Based on aggregated 13F filings for Q3 2024.